At the time of writing, Medpace Holdings Inc [MEDP] stock is trading at $302.69, up 1.60%. An important factor to consider is whether the stock is rising or falling in short-term value. The MEDP shares have gain 0.13% over the last week, with a monthly amount drifted -1.08%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Medpace Holdings Inc [NASDAQ: MEDP] stock has seen the most recent analyst activity on April 22, 2025, when William Blair downgraded its rating to a Mkt Perform. Previously, TD Cowen downgraded its rating to Hold on April 14, 2025, and kept the price target unchanged to $328. On March 24, 2025, Leerink Partners initiated with a Market Perform rating and assigned a price target of $330 on the stock. Robert W. Baird downgraded its rating to a Neutral and decreased its price target to $349 on October 23, 2024. Redburn Atlantic initiated its recommendation with a Buy. UBS downgraded its rating to Neutral for this stock on September 27, 2024, and downed its price target to $350. In a note dated September 25, 2024, Jefferies downgraded an Hold rating on this stock and revised its target price from $415 to $345.
For the past year, the stock price of Medpace Holdings Inc fluctuated between $250.05 and $459.77. Currently, Wall Street analysts expect the stock to reach $330 within the next 12 months. Medpace Holdings Inc [NASDAQ: MEDP] shares were valued at $302.69 at the most recent close of the market. An investor can expect a potential return of 9.02% based on the average MEDP price forecast.
Analyzing the MEDP fundamentals
According to Medpace Holdings Inc [NASDAQ:MEDP], the company’s sales were 2.16B for trailing twelve months, which represents an 9.30% jump. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.21%, Pretax Profit Margin comes in at 0.22%, and Net Profit Margin reading is 0.19%. To continue investigating profitability, this company’s Return on Assets is posted at 0.22, Equity is 0.54 and Total Capital is 0.59. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 296.36 points at the first support level, and at 290.03 for the second support level. However, for the 1st resistance point, the stock is sitting at 306.73, and for the 2nd resistance point, it is at 310.77.
Ratios To Look Out For
It is important to note that Medpace Holdings Inc [NASDAQ:MEDP] has a current ratio of 0.73. On the other hand, the Quick Ratio is 0.73, and the Cash Ratio is 0.39. Considering the valuation of this stock, the price to sales ratio is 4.03, the price to book ratio is 15.18 and price to earnings (TTM) ratio is 23.10.
Transactions by insiders
Recent insider trading involved DAVENPORT FRED B JR, Director, that happened on Apr 24 ’25 when 1712.0 shares were sold. Director, DAVENPORT FRED B JR completed a deal on Apr 24 ’25 to buy 1712.0 shares. Meanwhile, General Counsel & Corp. Secy. EWALD STEPHEN P bought 2.0 shares on Feb 27 ’25.
